Danaher Reports First Quarter 2026 Results

06:00am, Tuesday, 21'st Apr 2026
WASHINGTON, April 21, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2026.  All results in this release reflect only continuing operations and per
DHR heads into Q1 results with rising bioprocessing demand and steady estimates, but cost pressures and FX headwinds could weigh on performance.
Evaluate the expected performance of Danaher (DHR) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for
Border to Coast Pensions Partnership Ltd lessened its stake in Danaher Corporation (NYSE: DHR) by 41.5% in the undefined quarter, according to the company in its most recent Form 13F filing with the S
Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Modeling Shows Adoption of New Access MeMed BV Assay Could Cut up to €80M in Avoidable Costs across European Health Systems through Fewer Unnecessary Admissions and Testing  BREA, Calif., April 13
Dara Capital US Inc. purchased a new position in Danaher Corporation (NYSE: DHR) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange
Altfest L J and Co. Inc. lifted its holdings in shares of Danaher Corporation (NYSE: DHR) by 135.2% during the undefined quarter, according to its most recent disclosure with the Securities and Exchan
Bartlett and CO. Wealth Management LLC lowered its stake in Danaher Corporation (NYSE: DHR) by 7.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 63,4
Douglas Lane and Associates LLC lifted its stake in Danaher Corporation (NYSE: DHR) by 3.5% during the undefined quarter, according to its most recent disclosure with the SEC. The institutional invest
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible
CCLA Investment Management lessened its stake in shares of Danaher Corporation (NYSE: DHR) by 14.2% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 622,571 shar
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of M
Fulton Breakefield Broenniman LLC lowered its position in Danaher Corporation (NYSE: DHR) by 27.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange
Danaher is an American healthcare company that manufactures and markets products used for advances in biotechnology, life sciences, and diagnostics. Danaher has increased its dividend for 13 consecuti
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE